Status:
UNKNOWN
Validation of the French Version of the Lithium Knowledge Test (LKT)
Lead Sponsor:
University Hospital, Lille
Conditions:
Patient Treated With Lithium, With Bipolar or Schizo-affective Disorder, Hospitalized in a Psychiatric Ward
Eligibility:
All Genders
18+ years
Brief Summary
Lithium is a drug used to treat several psychiatric illnesses. This medication requires particular vigilance because it has a narrow therapeutic margin: the dose necessary to obtain an effective treat...
Eligibility Criteria
Inclusion
- Patient hospitalized in a psychiatric ward or in an EPSM for more than 10 consecutive days
- Patient treated with IR or ER lithium LI
- Patient over 18 years of
- Patient on a fixed dosage of lithium for more than 5 days prior to blood sampling for lithiaemia testing
- Obtain patient's non-opposition
Exclusion
- Clinically unstable patient or patient with a cognitive disorder that makes it impossible to perform interview and/or completion of the LKT self-questionnaire
- Patients under guardianship or trusteeship
- Illiterate patients
- Patient with a therapeutic target concentration different from general recommendations (e.g. elderly subject)
- Patient receiving a pharmaceutical interview or any other interview between the completion of the 1 and 2nd questionnaires, likely to modify the LKT score.
Key Trial Info
Start Date :
September 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 10 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06033326
Start Date
September 30 2023
End Date
October 10 2025
Last Update
September 13 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.